Volume | 191,095 |
|
|||||
News | - | ||||||
Day High | 0.7299 | Low High |
|||||
Day Low | 0.6833 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Cardio Diagnostics Holdings Inc | CDIO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.715 | 0.6833 | 0.7299 | 0.70 | 0.715 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
598 | 191,095 | $ 0.7006421 | $ 133,889 | - | 0.171 - 3.56 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:34:54 | 20 | $ 0.6804 | USD |
Cardio Diagnostics Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
14.36M | 20.52M | - | 17k | -8.38M | -0.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Cardio Diagnostics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CDIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.8725 | 0.89 | 0.6723 | 0.7281015 | 338,658 | -0.1428 | -16.37% |
1 Month | 0.75 | 1.12 | 0.6212 | 0.8572565 | 1,064,566 | -0.0203 | -2.71% |
3 Months | 1.62 | 1.82 | 0.6212 | 1.02 | 611,885 | -0.8903 | -54.96% |
6 Months | 2.12 | 3.56 | 0.6212 | 2.04 | 1,388,981 | -1.39 | -65.58% |
1 Year | 1.52 | 3.56 | 0.171 | 1.31 | 3,964,307 | -0.7903 | -51.99% |
3 Years | 4.25 | 8.4999 | 0.171 | 2.04 | 3,188,113 | -3.52 | -82.83% |
5 Years | 4.25 | 8.4999 | 0.171 | 2.04 | 3,188,113 | -3.52 | -82.83% |
Cardio Diagnostics Description
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. |